StonvexLoading…
StonvexStonvexStonvexCore line items from HAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $22.18B | $22.94B | $23.02B | $20.30B |
Operating Income | $2.26B | $3.82B | $4.08B | $2.71B |
Net Income | $1.28B | $2.50B | $2.64B | $1.57B |
EPS (Diluted) | $1.50 | $2.83 | $2.92 | $1.73 |
Total Assets | $25.01B | $25.59B | $24.68B | $23.25B |
Total Liabilities | $14.51B | $15.04B | $15.25B | $15.28B |
Cash & Equivalents | $2.21B | $2.62B | $2.26B | $2.35B |
Free Cash Flow OCF − CapEx | $1.67B | $2.42B | $2.08B | $1.23B |
Shares Outstanding | 835.00M | 868.00M | 889.00M | 902.00M |